Please provide your email address to receive an email when new articles are posted on . There are now sufficient data to show that switching early makes sense if a patient does not respond adequately ...

The risk for endophthalmitis after intravitreal steroid injections is almost seven times that seen after injections with anti–vascular endothelial growth factor (VEGF) agents, new research suggests.

A dexamethasone implant significantly outperformed ranibizumab (Lucentis) and methotrexate for intravitreal treatment of persistent/recurrent uveitic macular edema, according to results of a ...

Please provide your email address to receive an email when new articles are posted on . In this Healio Video Perspective, Dilraj Grewal, MD, discusses a case of melanoma-associated retinopathy in a ...

Injecting the corticosteroid triamcinolone into the eye may slow the progression of diabetic retinopathy, a complication of diabetes that can cause vision loss and blindness, according to a new study.

To determine the preliminary efficacy and safety of off-label dexamethasone implant for treatment of recurrent cystoid macular edema (CME) secondary to Irvine–Gass syndrome (IGS). This study was set ...

Expert Rev Ophthalmol. 2013;8(3):227-235. The use of anti-VEGF is rapidly becoming the standard of care for retinal vascular disease. There remains some concern regarding the duration of treatment; ...

SAN DIEGO, May 30, 2018 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc.'s (NASDAQ: IMMY) ophthalmology compounding division, ImprimisRx, is pleased to announce the findings from a study published in ...

To report on the follow-up of patients who received an intravitreal triamcinolone acetonide injection (IVTA) as treatment of exudative age-related macular degeneration. The prospective interventional ...

-- Robust efficacy and evidence of a dose response from single intravitreal injection (IVT) of ADVM-022 -- -- Long-term durability beyond 1 year from single IVT injection of ADVM-022 with zero rescue ...

Injecting the corticosteroid triamcinolone into the eye may slow the progression of diabetic retinopathy, a complication of diabetes that can cause vision loss and blindness, according to a report in ...